These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28783617)

  • 1. An age dependent response to hydroxyurea in pediatric sickle cell anemia patients with alpha thalassemia trait.
    Figueiredo L; Morrone K; Wei C; Ireland K; Cohen HW; Driscoll C; Manwani D
    Blood Cells Mol Dis; 2017 Jul; 66():19-23. PubMed ID: 28783617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and α-thalassemia.
    Ballas SK; Connes P;
    Eur J Haematol; 2018 Dec; 101(6):798-803. PubMed ID: 30204261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.
    Darbari DS; Nouraie M; Taylor JG; Brugnara C; Castro O; Ballas SK
    Eur J Haematol; 2014 Apr; 92(4):341-5. PubMed ID: 24330217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.
    Koren A; Segal-Kupershmit D; Zalman L; Levin C; Abu Hana M; Palmor H; Luder A; Attias D
    Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia.
    Yahouédéhou SCMA; da Guarda CC; Figueiredo CVB; Santiago RP; Carvalho SP; Fiuza LM; Ndidi US; Oliveira RM; Carvalho MOS; Nascimento VML; Rocha LC; Lyra IM; Adorno EV; Goncalves MS
    PLoS One; 2019; 14(7):e0218040. PubMed ID: 31306416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease.
    Rogers ZR
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):42-7. PubMed ID: 9317200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
    Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea therapy in children severely affected with sickle cell disease.
    Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
    J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
    Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
    Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
    Sheehan VA; Luo Z; Flanagan JM; Howard TA; Thompson BW; Wang WC; Kutlar A; Ware RE;
    Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth Hormone/Insulin-like Growth Factor 1 Axis Associated with Modifier Factors in Children with Sickle Cell Anemia.
    Costa-Júnior DAD; Santos APP; da Silva CM; Velloso-Rodrigues C
    Endocr Metab Immune Disord Drug Targets; 2022; 22(9):954-962. PubMed ID: 35240969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
    Estepp JH; Smeltzer MP; Kang G; Li C; Wang WC; Abrams C; Aygun B; Ware RE; Nottage K; Hankins JS
    Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N; Fattori A; Saad ST; Costa FF
    Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A; Gumruk F; Gurgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait.
    Adekile AD; Gupta R; Yacoub F; Sinan T; Al-Bloushi M; Haider MZ
    Acta Haematol; 2001; 105(1):27-31. PubMed ID: 11340250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha thalassemia, but not β
    Hatzlhofer BLD; Pereira-Martins DA; de Farias Domingos I; Arcanjo GDS; Weinhäuser I; Falcão DA; Farias ICC; de Freitas Batista JVG; Prado LPL; Oliveira JMF; Batista THC; Sobreira MJVC; de Santana RM; Araújo ABS; de Melo MA; de Ancântara BV; Coelho-Silva JL; de Moura Rafael ABL; de Lima Silva DM; Albuquerque FP; Santos MNN; Dos Anjos AC; Costa FF; da Silva Araújo A; Lucena-Araújo AR; Bezerra MAC
    Ann Hematol; 2021 Apr; 100(4):921-931. PubMed ID: 33586016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival.
    Rumaney MB; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Kengne AP; Ngogang J; Wonkam A
    PLoS One; 2014; 9(6):e100516. PubMed ID: 24978191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.